Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Cancer treatment has seen progress with protein kinase inhibitors, yet cancer evolution and heterogeneity pose significant challenges.
• Understanding cancer genomes is advancing rapidly due to omics technologies and bioinformatics.
• Cancer's complexity, driven by mutations and evolution, makes it a dynamic target requiring innovative research approaches.

Purpose of the Study:

• To review the challenges in treating cancers, focusing on their evolutionary and heterogeneous nature.
• To highlight current state-of-the-art research in computational methods, omics, and genome editing for cancer.
• To discuss the integration of computational approaches with experimental technologies for cancer therapy development.

Main Methods:

• Review of recent advancements in cancer research, including omics, bioinformatics, and genome editing.
• Analysis of computational methods for deciphering cancer molecular complexity and identifying driver mutations.
• Exploration of literature mining techniques to link cellular mechanisms to clinical outcomes.

Main Results:

• Cancer's heterogeneity and evolution present ongoing therapeutic challenges.
• Computational tools are crucial for understanding cancer genomes and identifying therapeutic targets.
• Emerging technologies like genome editing are paving the way for novel cancer treatments.

Conclusions:

• Despite successes, cancer's adaptability necessitates continuous research and development of new strategies.
• Integrating computational mining and advanced technologies like genome editing is key to overcoming cancer.
• Future cancer therapies will likely leverage a deep understanding of cancer's molecular underpinnings and evolutionary dynamics.